Trial intelligence / Profile preview

Biantong capsule for defecation-related cardiovascular risk in STEMI

ChiCTR1800017347Phase 4Not yet recruiting

Sponsor
Emergency & Critical Care Center, Beijing Anzhen Hospital
Start
Aug 2018
Countries
1
01

Overview

Phase 4 trial of Biantong capsule in myocardial infarction (MI) (2 arms), sponsored by Emergency & Critical Care Center, Beijing Anzhen Hospital. Primary endpoint: Composite cardiovascular endpoint events. Planned start Aug 2018; status: not yet recruiting.

02

Drugs

Biantong capsule
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on ChiCTR1800017347.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800017347.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call